Patient Misconception: PGT-A Does Not Guarantee "One-Time Success"
In outpatient clinics, patients often ask: "Is the success rate of PGT-A in Georgia high? I heard it can reach 80%?" This understanding has a fundamental deviation. The core value of PGT-A (Preimplantation Genetic Testing for Aneuploidy) is to screen for euploid embryos, reducing the risk of miscarriage and the birth of children with chromosomal abnormalities, but it cannot change egg quality or the developmental potential of the embryo itself. Fertility centers in Georgia typically publish the "clinical pregnancy rate per transfer cycle," not the "live birth rate per oocyte retrieval cycle." Assessing success rates must consider the patient's own fertility conditions.
Why There Is No Single Answer to This Question
The variation in PGT-A success rates in Georgia mainly stems from three aspects:
- Patient-specific factors: Female age, AMH level, antral follicle count, and history of miscarriage are core.
- Embryology laboratory standards: Blastocyst culture rate, biopsy technique stability, and gene amplification efficiency directly affect the number of transferable embryos.
- Differences in transfer strategy: Single embryo transfer vs. double embryo transfer, whether endometrial receptivity testing is performed, etc.
Therefore, any "success rate" data detached from a specific patient's situation has no reference value.
Specific Data Ranges by Age Group (Based on Real Fertility Center Annual Reports)
| Female Age | Average Embryos Obtained (Blastocysts) | Euploidy Rate After PGT-A | Clinical Pregnancy Rate per Single Transfer | Cumulative Live Birth Rate (Within 3 Transfers) |
|---|---|---|---|---|
| ≤35 years | 4-6 | 55%-65% | 60%-70% | 75%-85% |
| 36-39 years | 3-4 | 40%-50% | 50%-60% | 60%-70% |
| 40-42 years | 2-3 | 25%-35% | 35%-45% | 40%-50% |
| ≥43 years | 1-2 | 10%-20% | 15%-25% | 20%-30% |
How Doctors View PGT-A Success Rates in Georgia
From a reproductive specialist's perspective, assisted reproductive technology in Georgia is generally above average. Most正规 clinics use next-generation sequencing (NGS) for PGT-A, and biopsy laboratories hold CAP or ISO certifications. However, it is important to note: Georgia does not have a unified success rate registry, and data collection methods vary between institutions (some count "biochemical pregnancy," others count "ongoing pregnancy"). It is recommended that patients request to see the "clinical pregnancy rate per single transfer" and "cumulative live birth rate per oocyte retrieval cycle" for the past 1-2 years, rather than relying on verbal promises.
Easily Overlooked Detail: Limitations of PGT-A Itself
- Risk of misdiagnosing mosaic embryos: About 5%-10% of embryos have low-level mosaicism and may be incorrectly discarded as abnormal.
- Cannot screen for mitochondrial diseases or single-gene disorders (requires separate PGT-M).
- For women with poor egg quality (e.g., advanced age, premature ovarian insufficiency), PGT-A may result in "no embryos to transfer" due to a lack of euploid embryos, potentially reducing the cumulative live birth rate.
Candidates Suitable for PGT-A in Georgia
- Female age ≥38 years, recurrent implantation failure (≥2 attempts), recurrent miscarriage (≥2 losses), or known carrier of chromosomal structural abnormalities.
- Fertility centers with PGT-A technology certification, and embryology laboratories experienced in blastocyst culture and vitrification.
- Willingness to culture embryos to day 5-6 and acceptance of an approximately 20% risk of embryo damage due to biopsy.
Unsuitable Candidates and Risks
- AMH < 1.0 ng/mL and antral follicle count < 5: Low oocyte yield, low probability of blastocyst formation, and potentially no embryos available after PGT-A.
- Seeking PGT-A solely for sex selection (most countries prohibit non-medical sex screening; Georgian law is relatively lenient but still has ethical restrictions).
- Serious concerns about embryo biopsy or inability to afford additional genetic counseling costs.
Actual Process and Timeline
- Pre-treatment testing (completed in home country): AMH, FSH, LH, antral follicle ultrasound, semen analysis, karyotype, infectious disease screening — recommended 2-3 months in advance.
- Medical visa application for Georgia: Passport validity > 6 months required, typically allow 4-6 weeks.
- Ovarian stimulation (10-14 days): Starts on day 2-3 of menstruation, requiring regular monitoring of hormones and follicles.
- Egg retrieval surgery (30 minutes): Transvaginal retrieval under general anesthesia, with 2-hour post-operative observation.
- Embryo culture + biopsy (5-7 days): Trophectoderm biopsy after blastocyst culture, sent to the genetics laboratory.
- PGT-A testing (14-21 days): Endometrial preparation can be done while waiting for results.
- Frozen embryo transfer (cycle day 16-20): For natural cycle or hormone replacement cycle.
Factors Affecting Cost
The total cost of PGT-A in Georgia is approximately 80,000-150,000 RMB (including stimulation medication, egg retrieval, PGT-A, transfer, and some tests), which is lower than in the US and Western Europe. Key variables affecting cost:
- Whether multiple stimulation cycles are needed to accumulate embryos.
- PGT-A charges approximately 3,000-5,000 RMB per embryo; more embryos mean higher costs.
- Whether additional hysteroscopy or endometrial microbiome testing is required.
- Language translation and accommodation expenses (non-medical costs).
Interpreting Test Indicators: How to Predict Your Own Success Rate
- AMH: > 1.2 ng/mL indicates acceptable ovarian reserve; < 0.5 suggests diminished ovarian function.
- FSH: > 10 IU/L suggests reduced ovarian response.
- Antral Follicle Count (AFC): Total > 7 for both ovaries is considered good.
- Sperm DNA fragmentation index: > 30% may affect blastocyst formation rate.
Frequently Asked Questions
- Is there an age limit for PGT-A in Georgia?
- There is no legal age limit, but the probability of obtaining a euploid embryo after egg retrieval for women over 43 is less than 20%. Careful consideration is advised.
- How far in advance should I prepare?
- It is recommended to start at least 3-6 months in advance, especially for optimizing ovarian function, supplementing with Coenzyme Q10 and DHEA (under medical guidance).
- Can I bring my own stimulation medication to Georgia?
- Some hospitals allow it, but it requires original packaging, a prescription, and customs declaration. Purchasing locally is recommended to avoid transport失效.
Practitioner's Observation (Reproductive Specialist Perspective)
The number of fertility centers in Georgia has grown rapidly in the last 5 years, but technical standards vary. When choosing, pay attention to:
- Whether the laboratory has a dedicated, full-time embryologist (not part-time).
- Whether there is a multilingual medical record system (Chinese, English, Russian) to reduce communication errors.
- Whether time-lapse embryo monitoring is offered to assist in selecting the best embryo for transfer.
Doctor's Advice
Do not make "Is the PGT-A success rate in Georgia high?" the sole basis for your decision. The most rational approach is: first complete a comprehensive fertility assessment in your home country to obtain objective indicators like AMH, karyotype, and uterine cavity environment. Then, compare these with recent, individualized data from a specific clinic in Georgia (e.g., cycle numbers and live birth rates for patients of similar age and AMH range). If the assessment shows extremely poor ovarian reserve, the benefit of PGT-A is very limited, even at a top-tier clinic.
Comments (0)